"Etablissement de santé privé d’intérêt collectif, la Clinique Mutualiste propose aux patients une chirurgie et une médecine de haute qualité sans aucun dépassement d’honoraires."

During the past decade, Clinique Mutualiste conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Mutualiste" #1 sponsor was "Centre Hospitalier Universitaire de Saint Etienne" with 7 trials, followed by "UNICANCER" with 2 trials sponsored, "Zimmer Biomet" with 2 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored and "Clinique Mutualiste Chirurgicale de la Loire" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Mutualiste" #1 collaborator was "Biomet France SARL" with 2 trials as a collaborator, "CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Mutualiste" are "Arthritis" (2 trials), "Breast Cancer" (2 trials), "Morbid Obesity" (2 trials), "Prostate Cancer" (2 trials) and "Sars-CoV2" (2 trials). Many other conditions were trialed in "Clinique Mutualiste" in a lesser frequency.

Most popular intervention types in "Clinique Mutualiste" are "Drug" (7 trials), "Procedure" (6 trials), "Device" (5 trials), "Other" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Detection of arousal" (1 trials), "Enoxaparin" (1 trials), "Fenestrated Anaconda™ Device" (1 trials), "Flutamide" (1 trials) and "Hydroxychloroquine (HCQ)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Mutualiste" are 14 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Mutualiste". 1 are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Clinique Mutualiste, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Mutualiste, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".